191 related articles for article (PubMed ID: 16546280)
1. Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration.
Brooker S; Martin S; Pearson A; Bagchi D; Earl J; Gothard L; Hall E; Porter L; Yarnold J
Radiother Oncol; 2006 Apr; 79(1):45-51. PubMed ID: 16546280
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Gothard L; Cornes P; Earl J; Hall E; MacLaren J; Mortimer P; Peacock J; Peckitt C; Woods M; Yarnold J
Radiother Oncol; 2004 Nov; 73(2):133-9. PubMed ID: 15542159
[TBL] [Abstract][Full Text] [Related]
3. In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.
Ray SD; Patel D; Wong V; Bagchi D
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):137-66. PubMed ID: 11334364
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.
Donovan E; Bleakley N; Denholm E; Evans P; Gothard L; Hanson J; Peckitt C; Reise S; Ross G; Sharp G; Symonds-Tayler R; Tait D; Yarnold J;
Radiother Oncol; 2007 Mar; 82(3):254-64. PubMed ID: 17224195
[TBL] [Abstract][Full Text] [Related]
5. Unique organoprotective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced splenotoxicity and mocap-induced neurotoxicity in mice.
Ray SD; Wong V; Rinkovsky A; Bagchi M; Raje RR; Bagchi D
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):105-28. PubMed ID: 11334361
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract.
Bagchi D; Ray SD; Bagchi M; Preuss HG; Stohs SJ
Indian J Exp Biol; 2002 Jun; 40(6):717-26. PubMed ID: 12587719
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
[TBL] [Abstract][Full Text] [Related]
8. Ingestion of IH636 grape seed proanthocyanidin extract to prevent selenite-induced oxidative stress in experimental cataract.
Durukan AH; Evereklioglu C; Hurmeric V; Kerimoglu H; Erdurman C; Bayraktar MZ; Mumcuoglu T
J Cataract Refract Surg; 2006 Jun; 32(6):1041-5. PubMed ID: 16814068
[TBL] [Abstract][Full Text] [Related]
9. Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract.
Bagchi D; Ray SD; Patel D; Bagchi M
Drugs Exp Clin Res; 2001; 27(1):3-15. PubMed ID: 11276828
[TBL] [Abstract][Full Text] [Related]
10. Proanthocyanidin exposure to B6C3F1 mice significantly attenuates dimethylnitrosamine-induced liver tumor induction and mortality by differentially modulating programmed and unprogrammed cell deaths.
Ray SD; Parikh H; Bagchi D
Mutat Res; 2005 Nov; 579(1-2):81-106. PubMed ID: 16197968
[TBL] [Abstract][Full Text] [Related]
11. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.
Xu L; Li B; Cheng M; Zhang W; Pan J; Zhang C; Gao H
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):215-24. PubMed ID: 18273752
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis.
Delanian S; Porcher R; Balla-Mekias S; Lefaix JL
J Clin Oncol; 2003 Jul; 21(13):2545-50. PubMed ID: 12829674
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
18. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of grape seed extract against ischaemia/reperfusion injury in a rat epigastricflap model.
Karaaslan O; Ulusoy MG; Kankaya Y; Tiftikcioglu YO; Kocer U; Kankaya D; Karaaslan GM; Tuncer S; Berktas M
J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):705-10. PubMed ID: 19246271
[TBL] [Abstract][Full Text] [Related]
20. Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract.
Ray S; Bagchi D; Lim PM; Bagchi M; Gross SM; Kothari SC; Preuss HG; Stohs SJ
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):165-97. PubMed ID: 11758648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
